Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RANK: Varenicline nasal spray for post-LASIK dry eye
NCT05082974Phase 3Completed
- Sponsor
- Vance Thompson Vision
- Start
- Oct 2021
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of varenicline + nicotine patch in dry eye disease (DED), sponsored by Vance Thompson Vision. Started Oct 2021; status: completed.
02
Drugs
varenicline + nicotine patch
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT05082974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05082974.